#VisualAbstract: Treatment with empagliflozin reduced progression of chronic kidney disease
Click here to read this study in NEJM
Tag: chronic kidney disease
Chronic kidney disease associated with increased risk of spontaneous intracranial hemorrhage
1. Chronic kidney disease was independently associated with an increased risk of spontaneous intracranial hemorrhage, regardless of race or ethnicity. ...
Discrepancies exist between measured and estimated glomerular filtration rate
1. There are significant differences between measured and estimated glomerular filtration rate (mGFR and eGFR) at the individual patient level. ...
Comparisons of invasive versus conservative management in chronic kidney disease in the ISCHEMIA-CKD trials
1. Following invasive or conservative management of chronic coronary disease, patients with chronic kidney disease (CKD) stage 5 were found ...
Uric acid-lowering therapy not associated with improved kidney function
1. This retrospective cohort study demonstrated an increased risk of developing an estimated glomerular filtration rate (eGFR) less than 60 ...
Risk of chronic kidney disease progression may be greater amongst patients with obstructive sleep apnea
1. This study found moderate-to-very high risk of chronic kidney disease progression was greater in patients with more severe obstructive ...
Wellness Check: Sleep
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new ...
#VisualAbstract: Ziltivekimab antagonism of IL-6 reduces inflammation and thrombosis in patients with atherosclerotic risk factors
1. Ziltivekimab lowered high-sensitivity CRP levels, a predictor of vascular events, compared to placebo in a dose-dependent manner. 2. Thrombotic biomarkers including ...
Post-COVID Syndrome is linked to higher mortality risk and multi-organ dysfunction
1. Hospital readmission and mortality rates were higher in post-COVID patients as compared to matched control groups. 2. More diagnoses ...
#VisualAbstract: Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD Increases Risk of Major Cardiovascular Events and Mortality
1. Stopping renin-angiotensin system inhibition in patients with advanced chronic kidney disease was associated with higher risk of mortality, major cardiovascular ...
